tfa hynic-[d-phe1,tyr3-octreotide]
SpainDrugs containing this active substance
-
It is used to obtain images of specific cells in the stomach, intestines, and pancreas, such as tumors or abnormal tissue.
Form: radiopharmaceutical preparation kit
Active substance Dosage tfa hynic-[d-phe1,tyr3-octreotide] 16 µg Manufacturer: Rotop Pharmaka Gmbh